Alzheimer's disease: classification and diagnosis criteria
Keywordsdementia, Alzheimer's disease, diagnostic criteria
In recent years, the intensity of population aging has increased and the incidence of senile diseases, including dementia, has significantly increased. With the aging of populations in Europe, knowledge about the detection and diagnosis of dementia has increased in the last decade. Due to the increase in the number of patients, new therapies and precise diagnostic criteria have been introduced, contributing to faster diagnosis of the disease. Alzheimer's disease (AD) is the biggest cause of dementia in old age. It is characterized by progressive cognitive deficits, especially memory, and disorders such as: apathy, agitation and psychotic symptoms. Alzhaimer's disease is a degenerative brain disease caused by the deposition of pathological B-amyloid protein tau and alpha-synuclein in the brain, causing atrophy of neurons and their connections. The basis for diagnosis of dementia in the course of Alzheimer's disease are ICD-10 or DSM-IV criteria. The clinical course and symptoms in the course of AD are defined by the Global Deterioration Scale (GDS), the scale also determines the stage of the disease. Acetylcholinesterase inhibitor drugs and memantine are used to treat the symptoms of Alzheimer's disease. Prompt diagnosis and treatment significantly delays the progression of the disease and helps to prolong normal functioning of the patient.
Neugroschl J., Sano M.: An update on treatment and prevention strategies for Alzheimer’s disease. Curr.Neurol.Neurosci.Rep.2009;9:368-378.
YaffeK., Middleton L.E., Lui L.Y. I WSP.: Mild Cognitive impairment, dementi, and their subtypes In oldesoldwomen.Arch.NEUROL.2011;68:631-636.
Opala G.: Epidemiologia otępień w perspektywie prognoz demograficznych. W: Leszek J.(red.):Choroby otępienne .Teoria i praktyka. Wydawnictwo Continuo. Wrocław 2011.
Alzheimer’s Association:2015 Alzheimer’s disease facto and figures. Alzheimer‘s Dement 2015;11:332-384.
Albert MS, DeKosky ST, Dickson D et al. : The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on diagnostics guidelines for Alzheimer’s disease. Alzheimer‘s Dement 2011;7:270-279.
Gałecki P..Otępienie. W.Steciwko A. Medycyna Rodzinna - co nowego? Tom II Cornetis, Wrocław 2010:802-807.
Albert MS, DeKosky ST, Dickson D et al. :The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on diagnostics guidelines for Alzheimer’s disease. Alzheimer’s Dement 2011;7:270-279.
GabrylewiczT.,MandeckaM.:Wyzwania terapii otępienia w chorobie Alzheimera. Aktualn. Neurol.2013;13:103-108.
Barczak A. Wczesne rozpoznanie choroby Alzheimera. Pediatria Med. Rodz. 2018, 14(2):157-166.
Word Health Organization,ICD-10 Classification of Mental and Behavioral Disorders : Diagnostic Criteria for Research. WHO, Genewa 1993, Psychiatric Association, Washington 1994.
Winblad B. Palmer K., Kivipelto M. i wsp. Mild cognitive impairment beyond controversies, towards consensus: report of the International Working Group on MildCognitive impairment.I.Intern.Med.2004;25:240-246.
Knapmann D.S., DeKosky S.T., Cummings J.L. I wsp. Practice parameter: diagnosis of dementia (an evidence bared review). Report of Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1143-1153.
Reisberg B, Ferris SH, de Leon MJ et al.: Global Deterioration Scale (GDS). Psychopharmacol Bull 1988;24:661-663.
How to Cite
LicenseThe periodical offers access to content in the Open Access system under the Creative Commons non-exclusive license (CC BY-ND 4.0).
Number of views and downloads: 51
Number of citations: 0